Clinical Trial Update: A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 study of RBT-3 in healthy volunteers and patients with chronic kidney disease has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• RBT-3

Snippet

Sponsor: Renibus Therapeutics, Inc. | Conditions: Healthy Volunteers, Chronic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-03-03